Skip to main content
. Author manuscript; available in PMC: 2009 Dec 8.
Published in final edited form as: Mutat Res. 2006 Nov 20;627(1):92–105. doi: 10.1016/j.mrgentox.2006.10.006

Table 8.

Mouse (ICR) bone marrow micronucleus tests of the AstraZeneca MEK kinase inhibitor

Agent Dose (mg/kg) MNPCE/1000 PCE
% Centromere positive
MN from experiment 2
Experiment 1 (males) Experiment 1a (females) Experiment 2b (males)
Vehicle control 0 0.4 0.5 1.15 10
Test agent 500 0.3 0.5 2.55c 82
1000 0.7 0.5 3.28c 74
2000 2.5c 2.9c 2.72c 39
CPA (positive control) 50 19.3 21.5
65 27.5

All data is from bone marrows sampled 24 h after oral dosing (no effect at 48 h). PCE: polychromatic erythrocyte; MNPCE: micronucleated PCE; MN: micronuclei; CPA: cyclophosphamide.

a

Erythrocytes stained with May–Gruenwald–Giemsa.

b

Erythrocytes stained with Acridine Orange.

c

p < 0.05.